

Bavencio 200mg Injection (Avelumab)
Manufactured By
Merck
Pack Of
1
Salt Composition
Avelumab
Storage
Keep in cold place
Overview
Bavencio 200mg Injection is a prescription-based anticancer medicine used in the treatment of Sickle cell anemia, Merkel cell carcinoma, Urothelial, and Renal cell carcinoma. The active ingredient of the Bavencio is Avelumab which belongs to the drug class of PD-1/PD-L1 (programmed death ligand-1) inhibitors.
It works by blocking PD-L1 protein, which allows your immune system's T-cells to locate and destroy cancer cells. Avelumab Injection is usually given in combination with another anticancer medicine as a part of combination therapy to increase the efficacy of the treatment.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | bavencio |
| Generic / Active Ingredient | Bavencio |
| Strength | 200 |
| Dosage Form | Injection |
| Manufacturer / Marketer | Merck |
| Pack Size | 1 |
| Prescription Required | Yes |
| Therapeutic Categories | Cancer Medicines |
| Uses | Skin Cancer |
Uses and Indications
Skin cancer,Urothelial Carcinoma
Side Effects of Bavencio 200mg Injection
The human body shows undesired symptoms after taking Avelumab 200mg Injection (Bavencio). Usually, they disappear with time as the body adjusts to the medicine.
These side effects don't need special medical attention. It is advised to consult your doctor if these symptoms become unmanageable.
Common or Clinically Frequent Side Effects
- Some of the common side effects of Avelumab Injection are mentioned below:
- ● Increased blood pressure
- ● Swelling in the legs and feet
- ● Skin rash
- ● Abdominal pain
- ● Decrease in appetite
- ● Diarrhea
- ● Nausea
- ● Decreased RBC counts
- ● Muscle pain
- ● Cough, shortness of breath
- ● Difficulty in talking
- ● Tiredness
Serious Side Effects
- ● Heart problems
- ● Severe skin reactions
- ● Thyroid problems
- ● Liver injury
- ● Visual impairment
- ● Infusion reactions
Bavencio 200mg Injection Dosage and How To Take It
Bavencio 200mg Injection (Avelumab) is a prescription-based anticancer drug. It is advised to take this injection after consulting your healthcare expert. This medicine should be given intravenously by an experienced nurse or doctor. Please do not self-administer.
Safety Advice for Bavencio 200mg Injection
- ● Alcohol: The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking Avelumab 200mg Injection (Bavencio). It is advised to consult your doctor for further information.
- ● Pregnancy: Bavencio 200mg Injection (Avelumab) may be considered unsafe during pregnancy. Please consult your doctor in such condition.
- ● Breastfeeding: Avelumab 200mg Injection (Bavencio) is probably not safe if you're breastfeeding. Kindly consult your doctor.
- ● Driving: It is advisable not to drive or operate heavy machinery as you may feel dizzy after taking Bavencio 200mg Injection (Avelumab).
- ● Kidney: Share your medical history with your healthcare expert in case of kidney disease before taking Avelumab 200mg Injection (Bavencio).
- ● Liver: Inform your doctor before starting Bavencio 200mg Injection (Avelumab) if you have liver disease to avoid any serious side effects
FAQs About Bavencio 200mg Injection
What type of cancer is treated using Avelumab 200mg Injection (Bavencio)?
Bavencio 200mg Injection is a prescription based anticancer medicine used to treat Merkel cell carcinoma, Urothelial, and Renal cell carcinoma.
What type of drug is Bavencio?
Bavencio is a monoclonal antibody which is type of immunotherapy drug. It enhances the immune system to kill the cancer cells.
Can Avelumab 200mg Injection (Bavencio) work as combination drug?
Yes, Bavencio 200mg Injection is used as combination drug to increase the treatment effectiveness and to stop the growth of cancer cells.
How will Bavencio 200mg Injection (Avelumab) given to cancer patients?
Bavencio 200mg Injection should be given intravenously by an experienced nurse or doctor. Please do not self-administer.
What precautions should I take during treatment of Avelumab 200mg Injection (Bavencio)?
Avoid exposure to sun and infections, report if observe any unusual symptoms, and share your medical history with your healthcare expert, especially if you have autoimmune conditions, pregnant, planning to be pregnant, or breastfeeding.
References
● Vaishampayan, U., Schöffski, P., Ravaud, A., Borel, C., Peguero, J., Chaves, J., ... & Gulley, J. L. (2019). Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial. Journal for ImmunoTherapy of Cancer, 7(1), 275.
● Teets, A., Pham, L., Tran, E. L., Hochmuth, L., & Deshmukh, R. (2018). Avelumab: a novel anti-Pd-l1 agent in the treatment of merkel cell carcinoma and urothelial cell carcinoma. Critical Reviews™ in Immunology, 38(3).
● Shirley, M. (2018). Avelumab: a review in metastatic Merkel cell carcinoma. Targeted Oncology, 13(3), 409-416.
● Kim, E. S. (2017). Avelumab: first global approval. Drugs, 77(8), 929-937.
● Gunturi, A., & McDermott, D. F. (2015). Nivolumab for the treatment of cancer. Expert opinion on investigational drugs, 24(2), 253-260.
Marketer Details
Merck
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.


